CD36 and atherosclerosis: At the molecular level, the development of atherosclerosis is driven by the dysregulation of lipid metabolic proteins, including PCSK9, LOX-1, CD36, and ABCA1, which are key proteins that contribute to the atherosclerosis process and have important roles in lipid metabolism and the formation of atherosclerotic plaques.